Agenus | AGEN - Ebit


Agenus reported $15.05M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
AbbVie USD 6.88B 156M Sep/2026
Agenus USD 15.05M 656K Mar/2026
Amgen USD 4.68B 65M Sep/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Celldex Therapeutics USD -80.62M 3.81M Jun/2026
CSL USD 2.64B 116M Dec/2025
Eli Lilly USD 13.09B 635M Sep/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
Glaxosmithkline GBP 2.15B 157M Sep/2026
Incyte USD -707.47M 1.41B Sep/2026
Intrexon USD -26.3M 2.91M Jun/2024
J&J USD 6.47B 1B Sep/2026
Jiangsu Hengrui CNY 2.85B 1.17B Sep/2026
Karyopharm Therapeutics USD -26.76M 8.92M Mar/2026
MacroGenics USD -65.25M 33.36M Jun/2026
Merck EUR 1.1B 51M Jun/2026
Merck USD 7.33B 6.49B Sep/2026
Northwest Biotherapeutics USD -10.9M 3.42M Mar/2026
Novartis USD 5.14B 411M Sep/2026
Novavax USD 20.94M 100.32M Dec/2025
Pfizer USD 4.85B 5.03B Sep/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Veracyte USD 18.02M 5.94M Sep/2026